Digoxin-specific antibody fragments (Fab) can immediately reverse life-threatening arrhythmias and hyperkalemia caused by digoxin intoxication in pediatric patients.
Answers are grounded in this paper and cite their sources.
Supports Fab consideration in pediatric digoxin toxicity; single case leaves open need for controlled trials.
Digoxin-immune antibody fragments (Fab) for treatment of digitalis intoxication was introduced in 1976. Many reports have been published concerning this therapy for children, but few have focused on its immediate reversal of cardiac as well as extracardiac life-threatening manifestations of digoxin toxicity. We present a case of life-threatening digitalis intoxication in a child with postoperative renal insufficiency, after a Sennings procedure for transposition of the great arteries. Digoxin administration according to the nationally recommended dosage and intervals unexpectedly resulted in serum levels in the toxic range. Severe cardiac arrhythmias, haemodynamic instability and a rapid-increasing serum potassium level resulted. This report demonstrates how administration of Fab according to the manufacturer's dosage recommendation reversed the tachyarrhythmia immediately and re-established a normal level of serum potassium within minutes.
No takes yet. Share an insight, caveat, or question.
Husby et al. (2003) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: